FDA Approval: First Alzheimer’s Drug to Slow Disease

The US Food and Drug Administration is expected to decide on Thursday whether to grant traditional approval to the Alzheimer's drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.